Cyclic Di-GMP Signaling Contributes to Pseudomonas aeruginosa-Mediated Catheter-Associated Urinary Tract Infection
- PMID: 26195591
- PMCID: PMC4686188
- DOI: 10.1128/JB.00410-15
Cyclic Di-GMP Signaling Contributes to Pseudomonas aeruginosa-Mediated Catheter-Associated Urinary Tract Infection
Abstract
Bis-(3'-5') cyclic dimeric GMP (c-di-GMP) controls the lifestyle transition between the sessile and motile states in many Gram-negative bacteria, including the opportunistic human pathogen Pseudomonas aeruginosa. Under laboratory conditions, high concentrations of c-di-GMP decrease motility and promote biofilm formation, while low concentrations of c-di-GMP promote motility and decease biofilm formation. Here we sought to determine the contribution of c-di-GMP signaling to biofilm formation during P. aeruginosa-mediated catheter-associated urinary tract infection (CAUTI). Using a murine CAUTI model, a decrease in CFU was detected in the bladders and kidneys of mice infected with strains overexpressing the phosphodiesterases (PDEs) encoded by PA3947 and PA2133 compared to those infected with wild-type P. aeruginosa. Conversely, overexpression of the diguanylate cyclases (DGCs) encoded by PA3702 and PA1107 increased the number of bacteria in bladder and significantly increased dissemination of bacteria to the kidneys compared to wild-type infection. To determine which of the DGCs and PDEs contribute to c-di-GMP signaling during infection, a panel of PA14 in-frame deletion mutants lacking DGCs and PDEs were tested in the CAUTI model. Results from these infections revealed five mutants, three containing GGDEF domains (ΔPA14_26970, ΔPA14_72420, and ΔsiaD) and two containing dual GGDEF-EAL domains (ΔmorA and ΔPA14_07500), with decreased colonization of the bladder and dissemination to the kidneys. These results indicate that c-di-GMP signaling influences P. aeruginosa-mediated biofilms during CAUTI.
Importance: Biofilm-based infections are an important cause of nosocomial infections, since they resist the immune response and traditional antibiotic treatment. Cyclic di-GMP (c-di-GMP) is a second messenger that promotes biofilm formation in many Gram-negative pathogens, including Pseudomonas aeruginosa. Here we determined the contribution of c-di-GMP signaling to catheter-associated urinary tract infection (CAUTI), an animal model of biofilm-based infection. P. aeruginosa with elevated levels of c-di-GMP during the initial infection produces an increased bacterial burden in the bladder and kidneys. Conversely, low concentrations of c-di-GMP decreased the bacterial burden in the bladder and kidneys. We screened a library of mutants with mutations in genes regulating c-di-GMP signaling and found several mutants that altered colonization of the urinary tract. This study implicates c-di-GMP signaling during CAUTI.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.
Figures
Similar articles
-
More than Enzymes That Make or Break Cyclic Di-GMP-Local Signaling in the Interactome of GGDEF/EAL Domain Proteins of Escherichia coli.mBio. 2017 Oct 10;8(5):e01639-17. doi: 10.1128/mBio.01639-17. mBio. 2017. PMID: 29018125 Free PMC article.
-
Analysis of Pseudomonas aeruginosa diguanylate cyclases and phosphodiesterases reveals a role for bis-(3'-5')-cyclic-GMP in virulence.Proc Natl Acad Sci U S A. 2006 Feb 21;103(8):2839-44. doi: 10.1073/pnas.0511090103. Epub 2006 Feb 13. Proc Natl Acad Sci U S A. 2006. PMID: 16477007 Free PMC article.
-
Diguanylate Cyclases and Phosphodiesterases Required for Basal-Level c-di-GMP in Pseudomonas aeruginosa as Revealed by Systematic Phylogenetic and Transcriptomic Analyses.Appl Environ Microbiol. 2019 Oct 16;85(21):e01194-19. doi: 10.1128/AEM.01194-19. Print 2019 Nov 1. Appl Environ Microbiol. 2019. PMID: 31444209 Free PMC article.
-
Molecular and structural facets of c-di-GMP signalling associated with biofilm formation in Pseudomonas aeruginosa.Mol Aspects Med. 2021 Oct;81:101001. doi: 10.1016/j.mam.2021.101001. Epub 2021 Jul 24. Mol Aspects Med. 2021. PMID: 34311995 Review.
-
Biofilms and Cyclic di-GMP (c-di-GMP) Signaling: Lessons from Pseudomonas aeruginosa and Other Bacteria.J Biol Chem. 2016 Jun 10;291(24):12547-12555. doi: 10.1074/jbc.R115.711507. Epub 2016 Apr 21. J Biol Chem. 2016. PMID: 27129226 Free PMC article. Review.
Cited by
-
Association of Biofilm Inducer with bla VIM, bla IMP, and bla NDM in Pseudomonas aeruginosa Isolates.Arch Razi Inst. 2022 Oct 31;77(5):1723-1728. doi: 10.22092/ARI.2022.358104.2153. eCollection 2022 Oct. Arch Razi Inst. 2022. PMID: 37123152 Free PMC article.
-
Catheter-associated urinary tract infection by Pseudomonas aeruginosa progresses through acute and chronic phases of infection.Proc Natl Acad Sci U S A. 2022 Dec 13;119(50):e2209383119. doi: 10.1073/pnas.2209383119. Epub 2022 Dec 5. Proc Natl Acad Sci U S A. 2022. PMID: 36469780 Free PMC article.
-
Phenotypic and integrated analysis of a comprehensive Pseudomonas aeruginosa PAO1 library of mutants lacking cyclic-di-GMP-related genes.Front Microbiol. 2022 Jul 22;13:949597. doi: 10.3389/fmicb.2022.949597. eCollection 2022. Front Microbiol. 2022. PMID: 35935233 Free PMC article.
-
Slippery Liquid-Like Solid Surfaces with Promising Antibiofilm Performance under Both Static and Flow Conditions.ACS Appl Mater Interfaces. 2022 Feb 9;14(5):6307-6319. doi: 10.1021/acsami.1c14533. Epub 2022 Jan 31. ACS Appl Mater Interfaces. 2022. PMID: 35099179 Free PMC article.
-
Yin and Yang of Biofilm Formation and Cyclic di-GMP Signaling of the Gastrointestinal Pathogen Salmonella enterica Serovar Typhimurium.J Innate Immun. 2022;14(4):275-292. doi: 10.1159/000519573. Epub 2021 Nov 12. J Innate Immun. 2022. PMID: 34775379 Free PMC article. Review.
References
-
- Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK. 2008. NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 29:996–1011. doi:10.1086/591861. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
